The commercial development of Lo.Li. Pharma International in the breast care sector is amplified thanks to the partnership with ITF HELLAS, the Greek subsidiary of Italfarmaco Group. The timeline of operations has been defined: entry into Greece began in February 2021.

“This is not a first entry in this country, as the products branded Lo.Li. Pharma International brand products have already been marketed in Greece for several years, and with great success.” Rather, “The transaction is another very important piece of the development strategy planned for the coming years with our Partner with whom we continue to plan for the future, so much so that at the same time as the launch of Eumastos we are also renewing the Inofert line that has seen us as a leading player and leader in Greece for almost 10 years.” says Andrea Barsella, Head of Account Management at Lo.Li. Pharma International.

Lo.Li. Pharma International intends to consolidate or strengthen the relationship with its partners. This relationship must be based on a common desire for growth and, above all, on the Partner’s ability to invest together with Lo.Li. Pharma International in the markets of reference to bring innovative solutions to protect women’s health. For this reason Lo.Li. Pharma International has chosen Italfarmaco, an Italian multinational company founded in 1938 and currently operating in the pharmaceutical and chemical-pharmaceutical industry worldwide.